ArticlebioRxiv : the preprint server for biology2025
Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-density Lipoprotein Receptor Degradation.
Bo Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.